We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$191B
AUM Growth
+$34.6B
Cap. Flow
+$29.9B
Cap. Flow %
15.69%
Top 10 Hldgs %
11.5%
Holding
3,667
New
211
Increased
2,098
Reduced
1,163
Closed
105

Top Buys

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$905M
2
BMY icon
Bristol-Myers Squibb
BMY
+$786M
3
NVDA icon
NVIDIA
NVDA
+$736M
4
CNC icon
Centene
CNC
+$642M
5
AAPL icon
Apple
AAPL
+$451M

Top Sells

Rank Stock Value
1
MOH icon
Molina Healthcare
MOH
+$415M
2
INTC icon
Intel
INTC
+$329M
3
GM icon
General Motors
GM
+$237M
4
DASH icon
DoorDash
DASH
+$225M
5
INTU icon
Intuit
INTU
+$187M

Sector Composition

Rank Sector Weight
1 Technology 23.3%
2 Financials 15.19%
3 Healthcare 12.58%
4 Consumer Discretionary 12.42%
5 Industrials 12.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTEK
3551
Zentek
ZTEK
$84.2M
$19.3K ﹤0.01%
30,214
-135
-0.4% -$103
MRDN
3552
Meridian Holdings Inc
MRDN
$175M
$17K ﹤0.01%
+1,773
New +$19.4K
TSE
3553
DELISTED
Trinseo
TSE
$16.7K ﹤0.01%
33,646
+9,063
+37% +$10.8K
LFT
3554
Lument Finance Trust
LFT
$35.9M
$14.9K ﹤0.01%
+10,578
New +$16.9K
HURA
3555
TuHURA Biosciences
HURA
$142M
$12.5K ﹤0.01%
16,498
-17,567
-52% -$33.6K
REI icon
3556
Ring Energy
REI
$354M
$9.04K ﹤0.01%
10,392
-446,251
-98% -$425K
NMTC icon
3557
NeuroOne Medical Technologies
NMTC
$14M
$7.91K ﹤0.01%
1,739
-2
-0.1% -$9
RVPH
3558
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$7.81K ﹤0.01%
1,400
NVNO
3559
enVVeno Medical
NVNO
$7.31M
$6.71K ﹤0.01%
597
-55
-8% -$1.07K
SAFX
3560
XCF Global Inc
SAFX
$174M
$4.4K ﹤0.01%
+16,108
New +$12.5K
TVGN icon
3561
Tevogen Inc. Common Stock
TVGN
$27.3M
$4.32K ﹤0.01%
261
-195
-43% -$5.07K
APLT
3562
DELISTED
Applied Therapeutics
APLT
$1.34K ﹤0.01%
13,413
-96,274
-88% -$61.2K
AESI icon
3563
Atlas Energy Solutions
AESI
$1.51B
-15,403
Closed -$175K
AFYA icon
3564
Afya
AFYA
$1.22B
-18,807
Closed -$293K
AKRO
3565
DELISTED
Akero Therapeutics
AKRO
-65,966
Closed -$3.13M
ALE
3566
DELISTED
Allete
ALE
-542,011
Closed -$36M
ALXO icon
3567
ALX Oncology
ALXO
$274M
-10,793
Closed -$19.8K
AOA icon
3568
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.27B
-7,944
Closed -$700K
ARIS
3569
DELISTED
Aris Water Solutions
ARIS
-25,397
Closed -$626K
ATEX icon
3570
Anterix
ATEX
$1.87B
-19,459
Closed -$418K
ATNM icon
3571
Actinium Pharmaceuticals
ATNM
$24.5M
-16,805
Closed -$26.9K
AVDX
3572
DELISTED
AvidXchange
AVDX
-248,125
Closed -$2.47M
BALT icon
3573
Innovator Defined Wealth Shield ETF
BALT
$2.8B
-11,070
Closed -$363K
BDTX icon
3574
Black Diamond Therapeutics
BDTX
$116M
-18,026
Closed -$68.3K
BIZD icon
3575
VanEck BDC Income ETF
BIZD
$1.7B
-19,267
Closed -$288K

Similar funds

AQR Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, AQR Capital Management held 3,667 positions worth $191B, up 22% from $156B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

AQR Capital Management deployed $29.9B of net new capital in Q4 2025, opening 211 new positions and adding to 2,098 existing holdings. Its largest new stake was Celestica: 1,066,543 shares worth $315M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Molina Healthcare, an estimated $415M trimmed.

  • AQR Capital Management's largest Q4 2025 buy was Celestica: 1,066,543 shares worth $315M.
  • AQR Capital Management added most to Atlassian in Q4 2025, an estimated $905M increase.
  • AQR Capital Management's biggest Q4 2025 reduction was Molina Healthcare, cutting an estimated $415M.
  • AQR Capital Management fully exited Light & Wonder in Q4 2025, selling an estimated $70.7M.
  • AQR Capital Management's ten largest holdings make up 12% of its $191B portfolio in Q4 2025.
  • AQR Capital Management opened 211 new positions and closed 105 in Q4 2025.
  • AQR Capital Management's portfolio value rose 22% quarter-over-quarter to $191B.

Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.